GB1175468A – Pharmaceutical Compositions
– Google Patents
GB1175468A – Pharmaceutical Compositions
– Google Patents
Pharmaceutical Compositions
Info
Publication number
GB1175468A
GB1175468A
GB39730/68A
GB3973068A
GB1175468A
GB 1175468 A
GB1175468 A
GB 1175468A
GB 39730/68 A
GB39730/68 A
GB 39730/68A
GB 3973068 A
GB3973068 A
GB 3973068A
GB 1175468 A
GB1175468 A
GB 1175468A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
salts
physiologically compatible
sulphate
compatible salt
Prior art date
1967-10-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39730/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
E Merck AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1967-10-19
Filing date
1968-08-20
Publication date
1969-12-23
1967-10-19
Priority claimed from DE19671617654
external-priority
patent/DE1617654A1/en
1968-08-20
Application filed by E Merck AG
filed
Critical
E Merck AG
1969-12-23
Publication of GB1175468A
publication
Critical
patent/GB1175468A/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 – A61K41/00
A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/0012—Galenical forms characterised by the site of application
A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/0087—Galenical forms not covered by A61K9/02 – A61K9/7023
A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2004—Excipients; Inactive ingredients
A61K9/2013—Organic compounds, e.g. phospholipids, fats
A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Abstract
1,175,468. Pharmaceutical compositions. E. MERCK, A.G. 20 Aug., 1968 [19 Oct., 1967], No. 39730/68. Heading A5B. Pharmaceutical compositions for the treatment of climacteric disorders comprise at least one physiologically compatible salt of oestrone sulphate and at least one physiologically compatible salt of the 3-sulphate of 1, 3, 5 (10)- oestratriene-3, 17#-diol, together with a solid and/or liquid pharmaceutical diluent or carrier. The salts may be alkali metal, alkaline earth metal, aluminium, iron, ammonium or substituted ammonium salts, preferably the sodium salts. The compositions may be administered parenterally as solutions, suspensions, or emulsions or enterally as tablets, dragees, syrups or juices. The composition may contain at least one additional active substance which may be selected from tranquillising substances, vitamins and steroids (e.g. oestrogens, androgens or gestragens such as chlormadinone acetate). Stabilizers, e.g. diethanolamine, N-methyl-glucosamine, sodium citrate, sorensen’s buffer (a mixture of disodium hydrogen phosphate and potassium dihydrogen phosphate), and magnesium oxide may be present.
GB39730/68A
1967-10-19
1968-08-20
Pharmaceutical Compositions
Expired
GB1175468A
(en)
Applications Claiming Priority (1)
Application Number
Priority Date
Filing Date
Title
DE19671617654
DE1617654A1
(en)
1967-10-19
1967-10-19
drug
Publications (1)
Publication Number
Publication Date
GB1175468A
true
GB1175468A
(en)
1969-12-23
Family
ID=5682283
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
GB39730/68A
Expired
GB1175468A
(en)
1967-10-19
1968-08-20
Pharmaceutical Compositions
Country Status (9)
Country
Link
US
(1)
US3639599A
(en)
BE
(1)
BE722511A
(en)
BR
(1)
BR6803213D0
(en)
DK
(1)
DK120812B
(en)
ES
(1)
ES359336A1
(en)
FR
(1)
FR7983M
(en)
GB
(1)
GB1175468A
(en)
IL
(1)
IL30594A
(en)
SE
(1)
SE365408B
(en)
Families Citing this family (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE2645307A1
(en)
*
1976-10-05
1978-04-06
Schering Ag
NEW MEANS AND NEW METHODS FOR TREATING CLIMATE FAILURE
US4145416A
(en)
*
1976-06-23
1979-03-20
Schering, A.G.
Novel agents and novel methods for treatment of climacteric disturbances
US4390531A
(en)
*
1981-08-10
1983-06-28
Syntex Pharmaceuticals International Ltd.
Method of contraception using peak progestogen dosage
JPH0621072B2
(en)
*
1986-11-12
1994-03-23
呉羽化学工業株式会社
Immunomodulator consisting of estradiol derivative
US4946679A
(en)
*
1988-07-25
1990-08-07
Thys Jacobs Susan
Method for the treatment of premenstrual syndrome
US5354743A
(en)
*
1992-09-15
1994-10-11
Thys Jacobs Susan
Method for the treatment of premenstrual syndrome with vitamin D
KR20030090673A
(en)
*
2001-03-16
2003-11-28
와이어쓰
Estrogen Replacement Therapy
US20060040904A1
(en)
*
2004-08-17
2006-02-23
Ahmed Salah U
Vaginal cream compositions, kits thereof and methods of using thereof
EP1971325A2
(en)
*
2005-12-27
2008-09-24
Duramed Pharmaceuticals, Inc.
Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
WO2008100769A2
(en)
*
2007-02-09
2008-08-21
Wyeth
Process for selective sulfation of aromatic hydroxyl groups
1968
1968-08-20
GB
GB39730/68A
patent/GB1175468A/en
not_active
Expired
1968-08-21
IL
IL30594A
patent/IL30594A/en
unknown
1968-09-26
DK
DK464068AA
patent/DK120812B/en
unknown
1968-10-17
BR
BR203213/68A
patent/BR6803213D0/en
unknown
1968-10-18
SE
SE14106/68A
patent/SE365408B/xx
unknown
1968-10-18
BE
BE722511D
patent/BE722511A/xx
unknown
1968-10-18
FR
FR170470A
patent/FR7983M/fr
not_active
Expired
1968-10-19
ES
ES359336A
patent/ES359336A1/en
not_active
Expired
1970
1970-04-20
US
US30222A
patent/US3639599A/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
IL30594A0
(en)
1968-10-24
SE365408B
(en)
1974-03-25
BE722511A
(en)
1969-04-18
DK120812B
(en)
1971-07-19
US3639599A
(en)
1972-02-01
IL30594A
(en)
1972-05-30
FR7983M
(en)
1970-06-08
BR6803213D0
(en)
1973-04-26
ES359336A1
(en)
1970-07-01
Similar Documents
Publication
Publication Date
Title
FR7983M
(en)
1970-06-08
MY104375A
(en)
1994-03-31
Vitamin d derivatives and process for their preparation.
GB1171509A
(en)
1969-11-19
Pyridine Derivatives
GB1384768A
(en)
1975-02-19
Hair bleaching compositions and process
GB1359449A
(en)
1974-07-10
Combination preparations
GB1344558A
(en)
1974-01-23
Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
GB1278117A
(en)
1972-06-14
Stabilized 2-pam solutions
GB1403900A
(en)
1975-08-28
Pharmaceutical composition
IL39735A
(en)
1975-08-31
3,20-dioxo-pregn-4-ene-21-oic acid derivatives
GB1442159A
(en)
1976-07-07
Pharmaceutical compositions containing paracetamol
GB1512771A
(en)
1978-06-01
Piperazinyluracil salt
GB1257907A
(en)
1971-12-22
GB1291442A
(en)
1972-10-04
Adamantylamino-5,8-dihydronaphthyloxy-propanols and related compounds
GB1248727A
(en)
1971-10-06
Benzodiazepine derivatives
DK325584A
(en)
1985-01-16
15,16-METHYLENE-17ALFA-PREGNA-4,6-DIENE-21-CARBONIC ACID SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THESE AND PROCEDURES FOR THEIR PREPARATION
GB1402085A
(en)
1975-08-06
15-hydroxy vincamine
Hessel
1987
Combined Oral Contraceptives: From Risk to Benefit?
GB1266430A
(en)
1972-03-08
GB1178806A
(en)
1970-01-21
Pharmaceutical Preparations containing Butenoic Acid Derivatives
Garcia et al.
1989
Influence of pertussis toxin on parathyroid hormone stimulated cyclic AMP production and phosphate transport in opossum kidney cells
GB1312134A
(en)
1973-04-04
Hydrazino pyridazine derivatives
GB1289039A
(en)
1972-09-13
GB1514503A
(en)
1978-06-14
Strontium-silicon-aluminium master alloy
GB1247448A
(en)
1971-09-22
Steroidal triethylammonium salts and methods of preparing the same
Ueda et al.
1985
Geomagnetic total intensity anomaly map around Nansei-Syoto (Ryukyu Islands) at the scale of 1: 1,000,000.
Legal Events
Date
Code
Title
Description
1970-07-01
PS
Patent sealed [section 19, patents act 1949]
1971-08-11
PLE
Entries relating assignments, transmissions, licences in the register of patents
1979-03-21
PCNP
Patent ceased through non-payment of renewal fee
